Showing 2441-2450 of 4065 results for "".
- Digital Cognitive Assessments: Evaluating Feasibility for Dementia Screening in Primary Carehttps://reachmd.com/news/digital-cognitive-assessments-evaluating-feasibility-for-dementia-screening-in-primary-care/2474431/Digital cognitive assessments are gaining prominence as a compelling method for routine dementia screening within primary care settings. Recent evaluations confirm their effective integration into standard patient visits, providing an unsurpassed approach for the e
- Exploring the Role of Primary Care in Diagnosing Alcohol Use Disorder Versus Pharmacotherapy Prescribinghttps://reachmd.com/news/exploring-the-role-of-primary-care-in-diagnosing-alcohol-use-disorder-versus-pharmacotherapy-prescribing/2471829/Primary care visits are crucial for the early diagnosis of alcohol use disorder; however, translating these diagnoses into pharmacotherapy remains underutilized. This article dissects the diagnostic efficacy of primary care and the challenges of pharmacotherapy initiation.<
- Telehealth Offers Convenience for Rural Patients — But at What Cost?https://reachmd.com/news/telehealth-offers-convenience-for-rural-patients-but-at-what-cost/2467659/Remote healthcare delivery, commonly known as telehealth or telemedicine, is often beneficial for patients who have difficulty visiting their preferred healthcare providers in person. Use of the technology was rising steadily in the years leading up to the COVID-19 pandemic
- Cannabis Use Tied to Increased Risk of Severe COVID-19https://reachmd.com/news/cannabis-use-tied-to-increased-risk-of-severe-covid-19/2467134/Visit the News Hub Cannabis use tied to increased risk of severe COVID-19Similar to smokers, cannabis users nearly twice as likely to need hospitalization, intensive care when infected with
- Repurposed Drug May Help Stabilize Vision in Rare Diseasehttps://reachmd.com/news/repurposed-drug-may-help-stabilize-vision-in-rare-disease/2467084/Visit the News Hub Repurposed drug may help stabilize vision in rare diseaseClinical trial for RVCL-S patients tests drug already approved as sickle cell disease treatmentMatt Mil
- Risk of Death from COVID-19 Lessens, But Infection Still Can Cause Issues 3 Years Laterhttps://reachmd.com/news/risk-of-death-from-covid-19-lessens-but-infection-still-can-cause-issues-3-years-later/2463249/Visit the News Hub Risk of death from COVID-19 lessens, but infection still can cause issues 3 years laterStudy also shows that patients hospitalized within 30 days after infection face 29%
- Bronchiolitis: 2 French Studies Demonstrate the Effectiveness of Beyfortus® in Preventing Serious Illness and Reducing Hospital Admissions Among Infantshttps://reachmd.com/news/bronchiolitis-2-french-studies-demonstrate-the-effectiveness-of-beyfortus-in-preventing-serious-illness-and-reducing-hospital-admissions-among-infants/2463213/After a 2022/2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial virus (RSV), in particular in terms of emergency department visits and hospital admissions, on September 15, 2023 the French Government launched a preventive immunizatio
- New Data Identifies Trends in Accidental Opioid Overdoses in Childrenhttps://reachmd.com/news/new-data-identifies-trends-in-accidental-opioid-overdoses-in-children/2462775/Overall, prescription opioid overdose ED visits of US children had a decreasing trend during the past decade. Credit: frolicsomepl, Pixabay, CC0 (creativecommons.org/publicdomain/zero/1.0
- GE HealthCare Unveils Carestation 850: A Smarter Future for Anesthesia Deliveryhttps://reachmd.com/news/ge-healthcare-unveils-carestation-850-a-smarter-future-for-anesthesia-delivery/2483927/In a move poised to reshape the landscape of anesthesia technology, GE HealthCare has introduced its latest innovation: the Carestation 850, a next-ge
- AI Tool Unlocks Structural Secrets of Human Bitter Taste Receptorshttps://reachmd.com/news/unraveling-the-gut-brain-axis-from-bitter-taste-receptors-to-caloric-intake/2483476/Researchers have successfully used AlphaFold3, the latest evolution of DeepMind’s AI-powered protein prediction system, to generate accurate three-dimension